Siga Technologies (SIGA) Asset Writedowns and Impairment (2022 - 2025)
Siga Technologies' (SIGA) quarterly Asset Writedowns and Impairment came in at $400000.0 in Q3 2025, down 55.56% quarter-over-quarter from $900000.0 in Q2 2025.
Powered by 
Analysis
Siga Technologies (SIGA) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Asset Writedowns and Impairment for 2 consecutive years, with $400000.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Sep 2025 stood at $1.5 million (changed N/A YoY), and the FY2021 full-year result was $900000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment eased to $400000.0 in Q3 2025 per SIGA's latest filing, from $900000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $900000.0 in Q2 2025 and bottomed at $200000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2022 | 200,000.00 |